Robert Lemos

1.9k total citations
20 papers, 1.4k citations indexed

About

Robert Lemos is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Robert Lemos has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Robert Lemos's work include Cancer, Hypoxia, and Metabolism (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Robert Lemos is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Robert Lemos collaborates with scholars based in United States, South Korea and Australia. Robert Lemos's co-authors include Garth Powis, Mei Yee Koh, Xiuping Liu, Gordon B. Mills, Nathan T. Ihle, D. Lynn Kirkpatrick, Peter Wipf, Clint Mitchell, Doris R. Siwak and Paul Dent and has published in prestigious journals such as Hepatology, Cancer Research and Gut.

In The Last Decade

Robert Lemos

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Lemos United States	15	878	531	438	207	157	20	1.4k
Selma Pennacchietti Italy	10	1.1k 1.2×	661 1.2×	565 1.3×	344 1.7×	223 1.4×	11	1.9k
T. Annie T. Fong United States	7	1.3k 1.5×	555 1.0×	523 1.2×	231 1.1×	129 0.8×	10	1.8k
Alastair H. Kyle Canada	21	730 0.8×	410 0.8×	465 1.1×	207 1.0×	77 0.5×	49	1.5k
Steven Pirie‐Shepherd United States	19	815 0.9×	398 0.7×	356 0.8×	148 0.7×	102 0.6×	36	1.4k
Elizabeth A. Kuczynski Canada	12	681 0.8×	454 0.9×	373 0.9×	203 1.0×	90 0.6×	16	1.1k
Bárbara Sousa Portugal	19	841 1.0×	493 0.9×	550 1.3×	185 0.9×	231 1.5×	43	1.4k
Constadina Arvanitis United States	11	1.3k 1.5×	422 0.8×	637 1.5×	139 0.7×	124 0.8×	21	1.9k
Woondong Jeong United States	9	974 1.1×	402 0.8×	732 1.7×	164 0.8×	119 0.8×	23	1.5k
Jeff C. Liu Canada	19	897 1.0×	434 0.8×	660 1.5×	197 1.0×	64 0.4×	25	1.4k

Countries citing papers authored by Robert Lemos

Since Specialization

Citations

This map shows the geographic impact of Robert Lemos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lemos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lemos more than expected).

Fields of papers citing papers by Robert Lemos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lemos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lemos. The network helps show where Robert Lemos may publish in the future.

Co-authorship network of co-authors of Robert Lemos

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Lemos. A scholar is included among the top collaborators of Robert Lemos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Lemos. Robert Lemos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ihle, Nathan T., Geoffrey Grandjean, Michael J. Scott, et al.. (2019). An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors. Cancer Research. 79(12). 3100–3111. 23 indexed citations

Lemos, Robert, Guillermina Garcia, Brian P. James, et al.. (2019). Absence of HIF1A Leads to Glycogen Accumulation and an Inflammatory Response That Enables Pancreatic Tumor Growth. Cancer Research. 79(22). 5839–5848. 24 indexed citations

Jong, Petrus R. de, Alejandro D. Campos, Robert Lemos, et al.. (2018). Abstract 2916: Targeting lysophospholipid metabolism inhibits pancreatic cancer cell proliferation under nutrient-limiting conditions. Cancer Research. 78(13_Supplement). 2916–2916.

Lemos, Robert, et al.. (2017). Abstract 3015: Selective inhibition of mutant KRAS cell and tumor growth by PHT-7.3, an inhibitor of the KRas signaling nanocluster protein Cnk1. Cancer Research. 77(13_Supplement). 3015–3015. 1 indexed citations

Grandjean, Geoffrey, Petrus R. de Jong, Brian P. James, et al.. (2016). Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target. Cancer Research. 76(14). 4259–4269. 68 indexed citations

Koh, Mei Yee, Mihai Gagea, Robert Lemos, et al.. (2016). A new HIF‐1α/RANTES‐driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice. Hepatology. 63(5). 1576–1591. 33 indexed citations

Chang, Hae Ryung, Seungyoon Nam, Myeong‐Cherl Kook, et al.. (2014). HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. Gut. 65(1). 19–32. 95 indexed citations

Koh, Mei Yee, Robert Lemos, Bryant G. Darnay, et al.. (2014). Hypoxia-Induced SUMOylation of E3 Ligase HAF Determines Specific Activation of HIF2 in Clear-Cell Renal Cell Carcinoma. Cancer Research. 75(2). 316–329. 35 indexed citations

Jung, Hae Rim, Hae Ryung Chang, Robert Lemos, et al.. (2013). Abstract 5534: Metformin increases AMPKα activity by inhibition of AMPKα and cell cycle proliferation in Asian gastric cancer.. Cancer Research. 73(8_Supplement). 5534–5534. 1 indexed citations

10.

Mao, Muling, Feng Tian, John M. Mariadason, et al.. (2012). Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents. Clinical Cancer Research. 19(3). 657–667. 235 indexed citations

11.

Koh, Mei Yee, Robert Lemos, Xiuping Liu, & Garth Powis. (2011). The Hypoxia-Associated Factor Switches Cells from HIF-1α- to HIF-2α-Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion. Cancer Research. 71(11). 4015–4027. 276 indexed citations

12.

Kirkpatrick, D. Lynn, et al.. (2011). Abstract 4481: Topical application of the dual PDPK1/AKT inhibitor PHT-427 inhibits signaling and growth of human breast cancer cutaneous metastases in mice. Cancer Research. 71(8_Supplement). 4481–4481. 1 indexed citations

13.

Schwartz, David A., James A. Bankson, Robert Lemos, et al.. (2010). Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer. Molecular Cancer Therapeutics. 9(7). 2057–2067. 83 indexed citations

14.

Chen, Yunyun, Robert Lemos, Jeffrey N. Myers, et al.. (2010). Abstract 1401: Evaluation of vandetanib (ZD6474) and radiation therapy in an orthotopic xenograft model of anaplastic thyroid carcinoma. Cancer Research. 70(8_Supplement). 1401–1401. 1 indexed citations

15.

Meuillet, Emmanuelle J., Zuohe Song, Robert Lemos, et al.. (2010). Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor. Molecular Cancer Therapeutics. 9(3). 706–717. 66 indexed citations

16.

Song, Zuohe, Lei Du‐Cuny, Li Zhou, et al.. (2009). In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKT. Cancer Research. 69(12). 5073–5081. 48 indexed citations

17.

Bartholomeusz, Geoffrey, Paul Cherukuri, Laurent Cognet, et al.. (2009). In vivo therapeutic silencing of hypoxia-inducible factor 1 alpha (HIF-1α) using single-walled carbon nanotubes noncovalently coated with siRNA. Nano Research. 2(4). 279–291. 81 indexed citations

18.

Schwartz, David A., Garth Powis, Yi He, et al.. (2009). The selective hypoxia inducible factor-1 inhibitor PX-478 providesin vivoradiosensitization through tumor stromal effects. Molecular Cancer Therapeutics. 8(4). 947–958. 75 indexed citations

19.

Ihle, Nathan T., Robert Lemos, David A. Schwartz, et al.. (2009). Peroxisome proliferator-activated receptor γ agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activity. Molecular Cancer Therapeutics. 8(1). 94–100. 24 indexed citations

20.

Ihle, Nathan T., Robert Lemos, Peter Wipf, et al.. (2008). Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance. Cancer Research. 69(1). 143–150. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact